Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Tec-Dara significantly improves PFS and OS compared to SoC in relapsed/refractory multiple myeloma

Dr Luciano Costa - University Of Alabama At Birmingham, Birmingham, USA
Tec-Dara significantly improves PFS and OS compared to SoC in relapsed/refractory multiple myeloma ( Dr Luciano Costa - University Of Alabama At Birmingham, Birmingham, USA )
10 Dec 2025

Black patients show inferior survival despite similar cytogenetics and treatment response

Prof Shella Saint Fleur-Lominy - University of Maryland School of Medicine, Baltimore, USA
Black patients show inferior survival despite similar cytogenetics and treatment response ( Prof Shella Saint Fleur-Lominy - University of Maryland School of Medicine, Baltimore, USA )
10 Dec 2025

Rocbrutinib shows strong responses in resistant CLL, including BTKi- and venetoclax-exposed patients

Prof Jennifer Woyach - The Ohio State University, Columbus, USA
Rocbrutinib shows strong responses in resistant CLL, including BTKi- and venetoclax-exposed patients ( Prof Jennifer Woyach - The Ohio State University, Columbus, USA )
10 Dec 2025

Choosing Wisely: Managing resectable colorectal liver metastases

Dr Christopher Jackson - University of Otago, Otago, New Zeland
Choosing Wisely: Managing resectable colorectal liver metastases ( Dr Christopher Jackson - University of Otago, Otago, New Zeland )
7 Nov 2025

Optimal management of gastric cancers

Dr Prasanth Penumadu - Institution of Cancer Care & Advanced Research , Tirupati, India.
Optimal management of gastric cancers ( Dr Prasanth Penumadu - Institution of Cancer Care & Advanced Research , Tirupati, India. )
7 Nov 2025

Do all hormone sensitive prostate cancers need triplet therapy?

Dr Deepak Dabkara - Tata Medical Center, Kolkata, India
Do all hormone sensitive prostate cancers need triplet therapy? ( Dr Deepak Dabkara - Tata Medical Center, Kolkata, India )
7 Nov 2025

Choosing Wisely: ctDNA/ Precision Oncology in colorectal cancers

Dr Aparna Parikh - Massachusetts General Hospital, Boston, EE.UU
Choosing Wisely: ctDNA/ Precision Oncology in colorectal cancers ( Dr Aparna Parikh - Massachusetts General Hospital, Boston, EE.UU )
7 Nov 2025

Tarlatamab improves symptoms and QoL over chemo in previously treated SCLC

Dr Giannis Mountzios - Henry Dunant Hospital Center, Athens, Greece
Tarlatamab improves symptoms and QoL over chemo in previously treated SCLC ( Dr Giannis Mountzios - Henry Dunant Hospital Center, Athens, Greece )
4 Nov 2025

ESMO 2025: Latest developments in endometrial cancer

Dr Shannon Westin, Dr Brian Slomovitz, Dr Vanda Salutari and Dr Christian Marth
ESMO 2025: Latest developments in endometrial cancer ( Dr Shannon Westin, Dr Brian Slomovitz, Dr Vanda Salutari and Dr Christian Marth )
24 Oct 2025

ESMO 2025: Precision medicine in bladder cancer

Dr Enrique Grande, Prof Syed Hussain, Dr Patrizia Giannatempo, Dr Félix Guerrero-Ramos
ESMO 2025: Precision medicine in bladder cancer ( Dr Enrique Grande, Prof Syed Hussain, Dr Patrizia Giannatempo, Dr Félix Guerrero-Ramos )
23 Oct 2025

Tarlatamab plus chemo-IO shows promising efficacy in extensive stage SCLC

Professor Martin Wermke - National Center for Tumor Diseases, Dresden, Germany
Tarlatamab plus chemo-IO shows promising efficacy in extensive stage SCLC ( Professor Martin Wermke - National Center for Tumor Diseases, Dresden, Germany )
23 Oct 2025

ESMO 2025: Highlights and analysis

Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada
ESMO 2025: Highlights and analysis ( Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada )
23 Oct 2025